Malaysia Indranil Sen, managing director of Ranbaxy Malaysia, a Sun Pharma company, discusses the role of generics in the Malaysian pharmaceutical sector, and their strategy to lead the market, rather than becoming a “me too” generics company. What have been your main goals that you have set out to achieve…
Ranbaxy (UK) Ltd. (RUKL) You used to be the Managing Director of Ranbaxy in China. Having moved to a directorship in the UK, what professional challenges do you see in this country that distinguish it from your previous position? Obviously there are quite a lot of challenges in moving from one continent to another,…
See our Cookie Privacy Policy Here